The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction.
Daniel A JonesPaul WrightMomin A AlizadehSadeer FhadilKrishnaraj S RathodOliver GuttmannCharles KnightAdam TimmisAndreas BaumbachAndrew WraggAnthony MathurSotiris AntoniouPublished in: European heart journal. Cardiovascular pharmacotherapy (2022)
These data suggest improved thrombus resolution in post-acute coronary syndrome (ACS) LV thrombosis in patients treated with NOACs compared to VKAs. This improvement in thrombus resolution was accompanied with a better safety profile for NOAC patients vs. VKA-treated patients. Thus, provides data to support a randomized trial to answer this question.
Keyphrases
- acute coronary syndrome
- oral anticoagulants
- acute myocardial infarction
- end stage renal disease
- left ventricular
- ejection fraction
- newly diagnosed
- atrial fibrillation
- chronic kidney disease
- heart failure
- prognostic factors
- percutaneous coronary intervention
- peritoneal dialysis
- electronic health record
- aortic stenosis
- patient reported outcomes
- big data
- deep learning